Judith A Reuter

Title: Judith A Reuter: Innovator in Opiate Receptor Research

Introduction

Judith A Reuter is a notable inventor based in Skokie, IL (US). She has made significant contributions to the field of pharmacology, particularly in the development of enkephalin derivatives. With a total of 2 patents, her work has implications for pain management and non-addictive treatments.

Latest Patents

Reuter's latest patents include innovative compounds that exhibit agonist activity at opiate receptor sites. The first patent focuses on 4-Substituted enkephalin derivatives, which are analogs of methionine^5-enkephalin and leucine^5-enkephalin. These compounds have been shown to be useful as analgesics, non-addicting narcotic antagonists, and anti-diarrheal agents. The second patent involves 2 and 3-Substituted enkephalins, which also demonstrate agonist activity at opiate receptors, further supporting their potential as therapeutic agents.

Career Highlights

Judith A Reuter has had a distinguished career at G.D. Searle & Company, where she has been instrumental in advancing research on pain relief medications. Her innovative approach to drug development has positioned her as a key figure in her field.

Collaborations

Throughout her career, Reuter has collaborated with esteemed colleagues, including David A Jones, Jr and James M Schlatter. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Judith A Reuter's contributions to the field of pharmacology through her patents and collaborations highlight her role as an innovator in the development of non-addictive pain management solutions. Her work continues to influence the landscape of analgesic research.